Nyenta.com

Menu
  • Home
  • Business
  • Financial
  • Technology
  • Books
  • Entertainment
  • Music
  • Education
  • Non-profit
Menu

Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
Nyenta.com/10346722

Trending...
  • The New Sea of Possibility Has Opened: Quantum Oaks Calls Leaders to Shape the Quantum and AI Future
  • Annuity Innovator Carlton 'Cap' Averill II Shares Retirement Insights on "Moving America Forward"
  • New Thriller 'Counterframe' Explores the Hidden Vulnerabilities of Modern Society
Tennessee Laws
New laws highlight Tennessee's proactive response to growing concerns over psychiatric drug risks and potential links to violence. CCHR says these reforms are needed nationwide

LOS ANGELES - Nyenta -- Tennessee has enacted two landmark measures addressing psychotropic drug use. The first expands toxicology testing in cases of mass violence. The second requires detailed, privacy-protected reporting on prescriptions in Medicaid and foster care. The Citizens Commission on Human Rights (CCHR) International says these forward-looking reforms represent a strong and timely response to growing national concerns over psychiatric drug risks, demonstrating effective models of transparency and oversight that are urgently needed at the national and federal levels.

Tennessee lawmakers enacted a landmark measure that took effect July 1, 2025, requiring toxicology testing for psychotropic drugs in autopsies of decedents suspected of committing a mass shooting resulting in four or more deaths.[1] An enacted expansion (effective July 1, 2026) broadens this to those in which four or more individuals sustain injury (not limited to deaths), or where a reasonable person would conclude the perpetrator attempted to kill four or more individuals. It also extends provisions to living suspects: with probable cause, law enforcement may request consent for a blood or urine test to determine psychiatric drug presence.[2]

A key feature is the requirement to test for therapeutic levels of psychotropic drugs, allowing detection of even low amounts in the blood to identify recent or irregular intake that may still affect behavior. This establishes a critical new precedent for addressing potential drug-induced violence. Unlike past tragedies such as Sandy Hook, where toxicology testing omitted therapeutic levels, Tennessee's law now mandates these precise measurements.

Advocates say these measures set an important precedent for better understanding and addressing violence potentially linked to these prescription drugs.

Comprehensive Psychiatric Drug Tracking in Medicaid and Foster Care

A second new law, The Psychotropic Medication Data Transparency Act 2026, arose from a months-long effort to obtain psychotropic drug prescribing data that Tennessee had never consistently tracked. It mandates comprehensive collection and public reporting of psychotropic drug prescriptions for community use and the foster care system, and associated costs.[3]

More on Nyenta.com
  • Rebuilding investor confidence in quantum through better board education
  • Frankie Sly Takes on New Role as Face of Global Creators' Rights Campaign
  • UN Blockchain Week 2026: Priority Speaker Round Closes in 5 Days
  • Registration Open for Long Island Crisis Center's 18th Annual Suicide Prevention Walk
  • Fatal FOMO May be Your Last Roll of the Dice

In 2024, CCHR International filed Freedom of Information Act (FOIA) requests to gather data from 32 states on children prescribed psychotropic drugs under Medicaid and the costs. This found 9,882 children aged 0–5 were prescribed psychiatric drugs in 2023. After reviewing this information, Brittany Ruiz, Director of Public Policy for CCHR Tennessee, sought more Tennessee-specific data. As of January 2022, 25% of Tennesseans were taking psychotropic drugs—an increase of 15% from the prior year.[4] Approximately 1 in 3 foster children in Tennessee were on psychiatric drugs according to 2018 state-specific data, with more recent national Medicaid analyses showing rates near 35% as of 2023.[5]

Ruiz drafted the bill, which was championed by Representative Brock Martin and Senator Brent Taylor. With strong bipartisan support, it passed with nearly unanimous approval.

The collected reports include:
  • The number of persons prescribed at least one psychotropic drug, broken down by age groups: 0-5, 6-12, 13-17, 18-64, and 65 and older.
  • The number of distinct covered outpatient psychotropic drugs paid through TennCare per person over one year, categorized by county and age range.
  • The total cost of psychotropic drugs paid by TennCare, with separate subtotals for state and federal funds, categorized by age group.

A separate section addresses children in state custody (foster care), covering:
  • Numbers by age groups (birth to 5, 6-12, and 13-17).
  • The number of distinct psychotropic drugs prescribed per child over one year when received for 90 days or longer.
  • Total costs for these prescriptions.

All reports are prepared in aggregate, de-identified form to comply with privacy laws, demonstrating that effective oversight is possible without compromising patient privacy.

National Context and Call for Informed Consent

CCHR International's collected FOIA data from the 32 states showed that 2,999,084 children aged 0–17 were prescribed psychiatric drugs under Medicaid in 2023. This included 270,196 children aged 0–5, at a total taxpayer cost of $1.78 billion.[6]

ADHD stimulants (DEA Schedule II controlled substances) were the most commonly prescribed, given to more than 1.4 million children aged 0–17, including 89,392 aged 0–5. Antidepressants followed (920,411 children aged 0–17, including 25,414 aged 0–5), carrying an FDA black box warning for increased risk of suicidal thoughts and behaviors in youth. Anti-anxiety drugs were third (605,746 children aged 0–17, including 145,783 aged 0–5), with warnings about dependence and withdrawal. Antipsychotics were prescribed to 465,559 children aged 0–17 (including 34,758 aged 0–5), associated with risks such as diabetes, movement disorders, cardiovascular issues, and neuroleptic malignant syndrome.

More on Nyenta.com
  • Raja Limousine Expands Premium JFK Airport to Manhattan Car Service in 2026
  • WindowFixGuru™ Launches Special Savings on Wood Window Restoration in Nassau County
  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
  • Lorecentric Inc. Announces Official Launch as a New York Corporation
  • Bill Gray's Sponsors Kidtopia Summer Camp for Rochester-Area Children

These prescribing levels and documented risks demand greater informed consent. CCHR recommends that the FDA Medication Guide—plain-language fact sheets detailing the most serious side effects—be provided directly by prescribing doctors with signed patient acknowledgment. While pharmacists currently distribute them, CCHR calls for this to become a standard part of the physician's prescribing process.

Jan Eastgate, President of CCHR International, said: "Tennessee's dual landmark laws set a powerful new standard for transparency and accountability. They directly address growing concerns over the potential risks of these drugs, the urgent need for complete data, and persistently poor mental health outcomes. With federal measures now calling for deprescribing, it is time for comprehensive, transparent oversight to become the standard across America."

CCHR is a nonprofit mental health watchdog founded in 1969 by the Church of Scientology and professor of psychiatry Thomas Szasz, University of New York, Upstate Medical University. It has secured hundreds of laws protecting patient rights, including the U.S. Prohibition on Mandatory Medication amendment, banning children from being forced to take psychotropic drugs to remain in school.

Sources:

[1] "Tennessee Sets National Precedent with Passage of AbleChild Bill Requiring Psychotropic Drug Testing in Mass Shooter Cases," AbleChild, 30 Apr. 2025, www.ablechild.org/2026/05/21/tennessee-doubles-down-on-new-toxicology-law-that-broke-the-silence-on-psychiatric-drugs-mass-shootings/

[2] capitol.tn.gov/Bills/114/Bill/SB2088.pdf

[3] wapp.capitol.tn.gov/apps/BillInfo/Default?BillNumber=HB2389&ga=114

[4] Tennessee Accountability Center, "The Center for State Child Welfare Data – Tennessee Accountability Center Report," Department of Children's Services, 31 May 2018

[5] Keefe, Rachael J., et al., "Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees," Journal of Child and Adolescent Psychopharmacology, May 2023

[6] www.cchrint.org/massdrugging-of-medicaid-children/; Dr. Roger McFillin, "We Call It Medicine: The Mass Psychiatric Drugging of America's Poorest Children," Radically Genuine, 10 Mar. 2026, drmcfillin.substack.com/p/we-call-it-medicine-the-mass-psychiatric?utm_medium=email&action=share

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights International
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Nyenta.com
  • GPT-5.6 Family Is Now Available on Crun AI, Bringing Sol, Terra, and Luna to Developers
  • Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers
  • Where Is Your Faith The Movie and Sountrack
  • Djamee.com Unveils First-Ever Native Trading Bot for Coin Pick App Community
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • Rev-O-Box™ Launches Reversible Shipping Box That Instantly Becomes a Premium Gift Box
  • Opher Lichter Launches Fractional Advisory Firm OLS Consulting
  • Las Vegas Estate Firm Ghandi Deeter Blackham Offers Insight on Tony Hsieh's Contested $500 Million Will
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
  • Achugogo: Tale of the Spring Chaser Wins Inaugural TCCF Prize at Mifa Pitches, the Industry Market of the Annecy International Animation Film Festival
  • Saelig Introduces 4th Generation AIM-TTi PSA2704RT 2.7GHz Spectrum Analyzers
  • Storm Door Replacement and Repair Long Island for Homes in Nassau County
  • The Heel Vault Launches Shoe Care Center
  • URI House LLC Creates Events Through Bespoke Design
  • Dear Sarah, an AI Companion App Made for Women, Launches Today
  • Everything Policy Launches Madison, an AI Tool That Makes Legislation Readable for Students and Citizens
  • Xrorbit.com Review 2026: Users Highlight Trading Stability, Platform Clarity and Security Focus
  • Tocowallet.com Review 2026: Users Highlight Secure Transfers, Wallet Clarity and Everyday Usability

Popular on Nyenta

  • Dr. Stewart Nozette Releases New Techno-Thriller The Day of Infamy – Space Pearl Harbor - 449
  • The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth - 374
  • Mic King and Ghostface Killah Connect for new single, "COUNT ON IT" - 128
  • Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish" - 111
  • Middletown Volkswagen VW Oil Changes in Middletown, NY - 111
  • Middletown Mazda Publishes Guide to the 2026 Mazda CX-50 Hybrid for Hudson Valley Drivers - 110
  • De-Construction: EdgeStretching sets the city's machines loose - 108
  • Maddie's Motor Sports Features One of New York's Largest Powersports Inventories - 108
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers - 103
  • Route 9 Mazda Releases 2026 Mazda CX-30 Trim Level Guide for Hudson Valley Shoppers - 103

Similar on Nyenta

  • Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
  • Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • Healthcare Strategist Karl Durandis Announces the OneAmerica Initiative
  • Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026
  • Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
Copyright © 2026 nyenta.com | Terms of Service | Privacy Policy | Contribute | Contact Us